Month: July 2024

1917 posts
DP Technology Announces Nomination of Development Candidate, a CNS Penetrable Lp-PLA2 Inhibitor for Alzheimer's Disease

DP Technology Announces Nomination of Development Candidate, a CNS Penetrable Lp-PLA2 Inhibitor for Alzheimer's Disease

BEIJING, July 8, 2024 /PRNewswire/ — DP Technology, an "AI for Science"…
MGI Tech Partners with Australian Research Council Training Centre CEAStAR to Lead Innovation in Antimicrobial Resistance Solutions

MGI Tech Partners with Australian Research Council Training Centre CEAStAR to Lead Innovation in Antimicrobial Resistance Solutions

BRISBANE, Australia, July 8, 2024 /PRNewswire/ — MGI Australia Pty Ltd, subsidiary…
Vantage Markets elevates Copy Trading with Multi-Currency and Multi-Account Type support

Vantage Markets elevates Copy Trading with Multi-Currency and Multi-Account Type support

PORT VILA, Vanuatu, July 8, 2024 /PRNewswire/ — Leading multi-asset broker, Vantage Markets…

DPC Dash – Domino's Pizza China Concludes First Half of 2024 with Sustained Expansion and Innovation

HONG KONG, July 8, 2024 /PRNewswire/ — DPC Dash – Domino’s Pizza…

Uxin Announces Strategic Partnership with Zhengzhou Airport Industry

BEIJING, July 8, 2024 /PRNewswire/ — Uxin Limited ("Uxin" or the "Company",…
DP Technology Announces Nomination of Development Candidate, a Potential Best-in-Class Lp-PLA2 Inhibitor for DR and DME

DP Technology Announces Nomination of Development Candidate, a Potential Best-in-Class Lp-PLA2 Inhibitor for DR and DME

The nomination of novel Lp-PLA2 inhibitor DPT0415 for the treatment of DR…

Immorna Biotherapeutics Receives U.S. FDA IND Clearance to Conduct Phase 1/2 Study of JCXH-211 IV as Monotherapy and in Combination with Checkpoint Inhibitor in Patients with Advanced Solid Tumors

MORRISVILLE, NC., July 8, 2024 /PRNewswire/ — Immorna Biotherapeutics, Inc. (Immorna), a…

Copenhagen launches new green experience economy initiative, CopenPay

COPENHAGEN, Denmark, July 8, 2024 /PRNewswire/ — To get tourists to act more…